nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—Cytochrome P450 3A4 Inducers—Carbamazepine—epilepsy syndrome	0.251	0.541	CiPCiCtD
Mitotane—Cytochrome P450 3A4 Inducers—Topiramate—epilepsy syndrome	0.213	0.46	CiPCiCtD
Mitotane—CYP11A1—epilepsy syndrome	0.157	1	CbGaD
Mitotane—CYP11B1—Phenytoin—epilepsy syndrome	0.0937	1	CbGbCtD
Mitotane—Mazindol—Midazolam—epilepsy syndrome	0.0397	0.223	CrCrCtD
Mitotane—Mazindol—Diazepam—epilepsy syndrome	0.0354	0.199	CrCrCtD
Mitotane—Chlorcyclizine—Clobazam—epilepsy syndrome	0.0225	0.126	CrCrCtD
Mitotane—Delorazepam—Clonazepam—epilepsy syndrome	0.0216	0.121	CrCrCtD
Mitotane—Delorazepam—Midazolam—epilepsy syndrome	0.0206	0.116	CrCrCtD
Mitotane—Delorazepam—Clobazam—epilepsy syndrome	0.0198	0.111	CrCrCtD
Mitotane—Delorazepam—Diazepam—epilepsy syndrome	0.0184	0.103	CrCrCtD
Mitotane—SERPINA6—hindbrain—epilepsy syndrome	0.00078	0.084	CbGeAlD
Mitotane—FDX1—medulla oblongata—epilepsy syndrome	0.000721	0.0777	CbGeAlD
Mitotane—FDX1—midbrain—epilepsy syndrome	0.000659	0.071	CbGeAlD
Mitotane—SHBG—hindbrain—epilepsy syndrome	0.000657	0.0708	CbGeAlD
Mitotane—FDX1—spinal cord—epilepsy syndrome	0.000643	0.0693	CbGeAlD
Mitotane—FDX1—head—epilepsy syndrome	0.000572	0.0615	CbGeAlD
Mitotane—FDX1—nervous system—epilepsy syndrome	0.000542	0.0584	CbGeAlD
Mitotane—FDX1—central nervous system—epilepsy syndrome	0.000522	0.0562	CbGeAlD
Mitotane—FDX1—cerebellum—epilepsy syndrome	0.00051	0.0549	CbGeAlD
Mitotane—FDX1—brain—epilepsy syndrome	0.000414	0.0446	CbGeAlD
Mitotane—SHBG—brainstem—epilepsy syndrome	0.000377	0.0406	CbGeAlD
Mitotane—CYP11A1—medulla oblongata—epilepsy syndrome	0.000328	0.0353	CbGeAlD
Mitotane—CYP11A1—head—epilepsy syndrome	0.00026	0.028	CbGeAlD
Mitotane—SERPINA6—head—epilepsy syndrome	0.000247	0.0266	CbGeAlD
Mitotane—CYP11A1—nervous system—epilepsy syndrome	0.000246	0.0265	CbGeAlD
Mitotane—CYP11A1—central nervous system—epilepsy syndrome	0.000237	0.0255	CbGeAlD
Mitotane—SERPINA6—nervous system—epilepsy syndrome	0.000234	0.0252	CbGeAlD
Mitotane—SERPINA6—central nervous system—epilepsy syndrome	0.000226	0.0243	CbGeAlD
Mitotane—SERPINA6—cerebellum—epilepsy syndrome	0.00022	0.0237	CbGeAlD
Mitotane—SHBG—central nervous system—epilepsy syndrome	0.00019	0.0205	CbGeAlD
Mitotane—CYP11A1—brain—epilepsy syndrome	0.000188	0.0203	CbGeAlD
Mitotane—SHBG—cerebellum—epilepsy syndrome	0.000186	0.02	CbGeAlD
Mitotane—SERPINA6—brain—epilepsy syndrome	0.000179	0.0193	CbGeAlD
Mitotane—SHBG—brain—epilepsy syndrome	0.000151	0.0162	CbGeAlD
Mitotane—Mazindol—SLC6A4—epilepsy syndrome	0.000102	0.332	CrCbGaD
Mitotane—FDX1—Metabolism—PDXK—epilepsy syndrome	8.48e-05	0.00369	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CERS1—epilepsy syndrome	8.48e-05	0.00369	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ADK—epilepsy syndrome	8.48e-05	0.00369	CbGpPWpGaD
Mitotane—FDX1—Metabolism—L2HGDH—epilepsy syndrome	8.48e-05	0.00369	CbGpPWpGaD
Mitotane—FDX1—Metabolism—FAR1—epilepsy syndrome	8.48e-05	0.00369	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	8.42e-05	0.00366	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—POMC—epilepsy syndrome	8.21e-05	0.00357	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CRH—epilepsy syndrome	7.93e-05	0.00345	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GAMT—epilepsy syndrome	7.76e-05	0.00337	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NHLRC1—epilepsy syndrome	7.76e-05	0.00337	CbGpPWpGaD
Mitotane—FDX1—Metabolism—EPM2A—epilepsy syndrome	7.76e-05	0.00337	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PNPO—epilepsy syndrome	7.76e-05	0.00337	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—JUNB—epilepsy syndrome	7.74e-05	0.00337	CbGpPWpGaD
Mitotane—FDX1—Metabolism—QDPR—epilepsy syndrome	7.21e-05	0.00314	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CA4—epilepsy syndrome	7.21e-05	0.00314	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—POMC—epilepsy syndrome	7.19e-05	0.00313	CbGpPWpGaD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—PTGS2—epilepsy syndrome	7.06e-05	0.00307	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	6.78e-05	0.00295	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	6.78e-05	0.00295	CbGpPWpGaD
Mitotane—FDX1—Metabolism—COX3—epilepsy syndrome	6.78e-05	0.00295	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—JUNB—epilepsy syndrome	6.62e-05	0.00288	CbGpPWpGaD
Mitotane—FDX1—Metabolism—KCNB1—epilepsy syndrome	6.43e-05	0.0028	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SLC6A8—epilepsy syndrome	6.43e-05	0.0028	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PFKL—epilepsy syndrome	6.43e-05	0.0028	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CACNA2D2—epilepsy syndrome	6.43e-05	0.0028	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SLCO1A2—epilepsy syndrome	6.43e-05	0.0028	CbGpPWpGaD
Mitotane—Carbinoxamine—CYP2C19—epilepsy syndrome	6.29e-05	0.205	CrCbGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	6.28e-05	0.00273	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	6.24e-05	0.00272	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—IL18—epilepsy syndrome	6e-05	0.00261	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	5.95e-05	0.00259	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NEU1—epilepsy syndrome	5.88e-05	0.00256	CbGpPWpGaD
Mitotane—FDX1—Metabolism—UPB1—epilepsy syndrome	5.88e-05	0.00256	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ATIC—epilepsy syndrome	5.88e-05	0.00256	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP2C19—epilepsy syndrome	5.83e-05	0.00253	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	5.8e-05	0.00252	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	5.8e-05	0.00252	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP11A1—epilepsy syndrome	5.79e-05	0.00252	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	5.75e-05	0.0025	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	5.71e-05	0.00248	CbGpPWpGaD
Mitotane—FDX1—Metabolism—HSD17B4—epilepsy syndrome	5.66e-05	0.00246	CbGpPWpGaD
Mitotane—Chlorphenamine—SLC6A4—epilepsy syndrome	5.64e-05	0.183	CrCbGaD
Mitotane—FDX1—Metabolism—PPP1R3C—epilepsy syndrome	5.46e-05	0.00238	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GBE1—epilepsy syndrome	5.46e-05	0.00238	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	5.34e-05	0.00232	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP2D6—epilepsy syndrome	5.23e-05	0.00227	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	5.15e-05	0.00224	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	5.14e-05	0.00224	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ASAH1—epilepsy syndrome	5.14e-05	0.00223	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—IL18—epilepsy syndrome	5.13e-05	0.00223	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	5.09e-05	0.00221	CbGpPWpGaD
Mitotane—FDX1—Metabolism—STXBP1—epilepsy syndrome	5e-05	0.00217	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—CYP2C19—epilepsy syndrome	4.98e-05	0.00217	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	4.92e-05	0.00214	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NT5E—epilepsy syndrome	4.87e-05	0.00212	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ALAD—epilepsy syndrome	4.87e-05	0.00212	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.82e-05	0.0021	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.7e-05	0.00205	CbGpPWpGaD
Mitotane—Carbinoxamine—CYP2D6—epilepsy syndrome	4.66e-05	0.152	CrCbGaD
Mitotane—FDX1—Metabolism—CACNA1A—epilepsy syndrome	4.65e-05	0.00202	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ALDH7A1—epilepsy syndrome	4.65e-05	0.00202	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—PRKCB—epilepsy syndrome	4.64e-05	0.00202	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ST3GAL3—epilepsy syndrome	4.55e-05	0.00198	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	4.53e-05	0.00197	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—CYP2D6—epilepsy syndrome	4.47e-05	0.00195	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ADSL—epilepsy syndrome	4.45e-05	0.00194	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	4.41e-05	0.00192	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	4.4e-05	0.00191	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GLUL—epilepsy syndrome	4.37e-05	0.0019	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CACNA1D—epilepsy syndrome	4.29e-05	0.00187	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—FOS—epilepsy syndrome	4.23e-05	0.00184	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—POMC—epilepsy syndrome	4.22e-05	0.00184	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.12e-05	0.00179	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	4.11e-05	0.00179	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	4.02e-05	0.00175	CbGpPWpGaD
Mitotane—FDX1—Metabolism—TXNRD1—epilepsy syndrome	4.01e-05	0.00174	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CA13—epilepsy syndrome	3.99e-05	0.00173	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—PRKCB—epilepsy syndrome	3.97e-05	0.00173	CbGpPWpGaD
Mitotane—Chlorphenamine—CYP2D6—epilepsy syndrome	3.96e-05	0.129	CrCbGaD
Mitotane—FDX1—Metabolism—AQP1—epilepsy syndrome	3.89e-05	0.00169	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	3.87e-05	0.00168	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.74e-05	0.00163	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—FOS—epilepsy syndrome	3.62e-05	0.00157	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—POMC—epilepsy syndrome	3.61e-05	0.00157	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—BCL2—epilepsy syndrome	3.55e-05	0.00154	CbGpPWpGaD
Mitotane—FDX1—Metabolism—KCNJ11—epilepsy syndrome	3.52e-05	0.00153	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CHRM3—epilepsy syndrome	3.52e-05	0.00153	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.52e-05	0.00153	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—RELA—epilepsy syndrome	3.47e-05	0.00151	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CA13—epilepsy syndrome	3.41e-05	0.00148	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.28e-05	0.00143	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.21e-05	0.0014	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.21e-05	0.0014	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CASP3—epilepsy syndrome	3.13e-05	0.00136	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—BCL2—epilepsy syndrome	3.03e-05	0.00132	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—FAR1—epilepsy syndrome	3.02e-05	0.00131	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—L2HGDH—epilepsy syndrome	3.02e-05	0.00131	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ADK—epilepsy syndrome	3.02e-05	0.00131	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GLUD1—epilepsy syndrome	3.02e-05	0.00131	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CERS1—epilepsy syndrome	3.02e-05	0.00131	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PDXK—epilepsy syndrome	3.02e-05	0.00131	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—RELA—epilepsy syndrome	2.97e-05	0.00129	CbGpPWpGaD
Mitotane—Asthenia—Vigabatrin—epilepsy syndrome	2.91e-05	0.000385	CcSEcCtD
Mitotane—Decreased appetite—Lamotrigine—epilepsy syndrome	2.9e-05	0.000384	CcSEcCtD
Mitotane—Infestation—Topiramate—epilepsy syndrome	2.9e-05	0.000384	CcSEcCtD
Mitotane—Infestation NOS—Topiramate—epilepsy syndrome	2.9e-05	0.000384	CcSEcCtD
Mitotane—Eye disorder—Gabapentin—epilepsy syndrome	2.89e-05	0.000383	CcSEcCtD
Mitotane—Dizziness—Midazolam—epilepsy syndrome	2.88e-05	0.000382	CcSEcCtD
Mitotane—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	2.88e-05	0.000381	CcSEcCtD
Mitotane—Body temperature increased—Clonazepam—epilepsy syndrome	2.88e-05	0.000381	CcSEcCtD
Mitotane—Dysgeusia—Pregabalin—epilepsy syndrome	2.88e-05	0.000381	CcSEcCtD
Mitotane—FDX1—Metabolism—ABCG2—epilepsy syndrome	2.87e-05	0.00125	CbGpPWpGaD
Mitotane—Asthenia—Diazepam—epilepsy syndrome	2.86e-05	0.000379	CcSEcCtD
Mitotane—Body temperature increased—Phenytoin—epilepsy syndrome	2.86e-05	0.000378	CcSEcCtD
Mitotane—Pain—Lamotrigine—epilepsy syndrome	2.85e-05	0.000378	CcSEcCtD
Mitotane—Nausea—Acetazolamide—epilepsy syndrome	2.85e-05	0.000377	CcSEcCtD
Mitotane—Dizziness—Levetiracetam—epilepsy syndrome	2.85e-05	0.000377	CcSEcCtD
Mitotane—Feeling abnormal—Carbamazepine—epilepsy syndrome	2.85e-05	0.000377	CcSEcCtD
Mitotane—Body temperature increased—Oxcarbazepine—epilepsy syndrome	2.84e-05	0.000376	CcSEcCtD
Mitotane—Diarrhoea—Fosphenytoin—epilepsy syndrome	2.84e-05	0.000376	CcSEcCtD
Mitotane—Vomiting—Propofol—epilepsy syndrome	2.83e-05	0.000375	CcSEcCtD
Mitotane—Rash—Propofol—epilepsy syndrome	2.81e-05	0.000372	CcSEcCtD
Mitotane—Dermatitis—Propofol—epilepsy syndrome	2.81e-05	0.000372	CcSEcCtD
Mitotane—Hypertension—Valproic Acid—epilepsy syndrome	2.81e-05	0.000371	CcSEcCtD
Mitotane—FDX1—Metabolism—CYP2C19—epilepsy syndrome	2.8e-05	0.00122	CbGpPWpGaD
Mitotane—Headache—Propofol—epilepsy syndrome	2.79e-05	0.00037	CcSEcCtD
Mitotane—Hypersensitivity—Zonisamide—epilepsy syndrome	2.78e-05	0.000368	CcSEcCtD
Mitotane—FDX1—Metabolism—CYP11A1—epilepsy syndrome	2.78e-05	0.00121	CbGpPWpGaD
Mitotane—Vomiting—Midazolam—epilepsy syndrome	2.77e-05	0.000367	CcSEcCtD
Mitotane—Diarrhoea—Vigabatrin—epilepsy syndrome	2.77e-05	0.000367	CcSEcCtD
Mitotane—Asthenia—Felbamate—epilepsy syndrome	2.77e-05	0.000367	CcSEcCtD
Mitotane—Vision blurred—Pregabalin—epilepsy syndrome	2.77e-05	0.000366	CcSEcCtD
Mitotane—Haematuria—Topiramate—epilepsy syndrome	2.77e-05	0.000366	CcSEcCtD
Mitotane—CYP11B1—Metabolism—GAMT—epilepsy syndrome	2.76e-05	0.0012	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NHLRC1—epilepsy syndrome	2.76e-05	0.0012	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—EPM2A—epilepsy syndrome	2.76e-05	0.0012	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PNPO—epilepsy syndrome	2.76e-05	0.0012	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.76e-05	0.0012	CbGpPWpGaD
Mitotane—Tremor—Pregabalin—epilepsy syndrome	2.75e-05	0.000364	CcSEcCtD
Mitotane—Feeling abnormal—Lamotrigine—epilepsy syndrome	2.75e-05	0.000364	CcSEcCtD
Mitotane—Rash—Midazolam—epilepsy syndrome	2.75e-05	0.000364	CcSEcCtD
Mitotane—Dizziness—Fosphenytoin—epilepsy syndrome	2.75e-05	0.000364	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	2.75e-05	0.000364	CcSEcCtD
Mitotane—Dermatitis—Midazolam—epilepsy syndrome	2.75e-05	0.000364	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.74e-05	0.00119	CbGpPWpGaD
Mitotane—Vomiting—Levetiracetam—epilepsy syndrome	2.74e-05	0.000362	CcSEcCtD
Mitotane—Headache—Midazolam—epilepsy syndrome	2.73e-05	0.000362	CcSEcCtD
Mitotane—Body temperature increased—Carbamazepine—epilepsy syndrome	2.73e-05	0.000361	CcSEcCtD
Mitotane—Diarrhoea—Diazepam—epilepsy syndrome	2.73e-05	0.000361	CcSEcCtD
Mitotane—Rash—Levetiracetam—epilepsy syndrome	2.72e-05	0.000359	CcSEcCtD
Mitotane—Anaemia—Pregabalin—epilepsy syndrome	2.72e-05	0.000359	CcSEcCtD
Mitotane—Dermatitis—Levetiracetam—epilepsy syndrome	2.71e-05	0.000359	CcSEcCtD
Mitotane—Asthenia—Zonisamide—epilepsy syndrome	2.71e-05	0.000359	CcSEcCtD
Mitotane—Mental disorder—Gabapentin—epilepsy syndrome	2.71e-05	0.000359	CcSEcCtD
Mitotane—Headache—Levetiracetam—epilepsy syndrome	2.7e-05	0.000357	CcSEcCtD
Mitotane—Malnutrition—Gabapentin—epilepsy syndrome	2.69e-05	0.000356	CcSEcCtD
Mitotane—Hypersensitivity—Clonazepam—epilepsy syndrome	2.68e-05	0.000355	CcSEcCtD
Mitotane—Dizziness—Vigabatrin—epilepsy syndrome	2.68e-05	0.000355	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CASP3—epilepsy syndrome	2.68e-05	0.00116	CbGpPWpGaD
Mitotane—Confusional state—Valproic Acid—epilepsy syndrome	2.67e-05	0.000354	CcSEcCtD
Mitotane—Hypersensitivity—Phenytoin—epilepsy syndrome	2.67e-05	0.000353	CcSEcCtD
Mitotane—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	2.65e-05	0.000351	CcSEcCtD
Mitotane—Nausea—Propofol—epilepsy syndrome	2.65e-05	0.00035	CcSEcCtD
Mitotane—Vomiting—Fosphenytoin—epilepsy syndrome	2.64e-05	0.00035	CcSEcCtD
Mitotane—Diarrhoea—Felbamate—epilepsy syndrome	2.64e-05	0.00035	CcSEcCtD
Mitotane—Vertigo—Pregabalin—epilepsy syndrome	2.64e-05	0.000349	CcSEcCtD
Mitotane—Body temperature increased—Lamotrigine—epilepsy syndrome	2.64e-05	0.000349	CcSEcCtD
Mitotane—Dysgeusia—Gabapentin—epilepsy syndrome	2.64e-05	0.000349	CcSEcCtD
Mitotane—Dizziness—Diazepam—epilepsy syndrome	2.64e-05	0.000349	CcSEcCtD
Mitotane—Infection—Valproic Acid—epilepsy syndrome	2.63e-05	0.000349	CcSEcCtD
Mitotane—Rash—Fosphenytoin—epilepsy syndrome	2.62e-05	0.000347	CcSEcCtD
Mitotane—Dermatitis—Fosphenytoin—epilepsy syndrome	2.62e-05	0.000346	CcSEcCtD
Mitotane—Asthenia—Clonazepam—epilepsy syndrome	2.61e-05	0.000346	CcSEcCtD
Mitotane—Headache—Fosphenytoin—epilepsy syndrome	2.6e-05	0.000345	CcSEcCtD
Mitotane—Hepatitis—Topiramate—epilepsy syndrome	2.6e-05	0.000345	CcSEcCtD
Mitotane—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.6e-05	0.000344	CcSEcCtD
Mitotane—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.6e-05	0.000344	CcSEcCtD
Mitotane—Asthenia—Phenytoin—epilepsy syndrome	2.6e-05	0.000343	CcSEcCtD
Mitotane—Nausea—Midazolam—epilepsy syndrome	2.59e-05	0.000343	CcSEcCtD
Mitotane—Diarrhoea—Zonisamide—epilepsy syndrome	2.59e-05	0.000342	CcSEcCtD
Mitotane—CYP11A1—Metabolism—L2HGDH—epilepsy syndrome	2.58e-05	0.00112	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PDXK—epilepsy syndrome	2.58e-05	0.00112	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—FAR1—epilepsy syndrome	2.58e-05	0.00112	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GLUD1—epilepsy syndrome	2.58e-05	0.00112	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ADK—epilepsy syndrome	2.58e-05	0.00112	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CERS1—epilepsy syndrome	2.58e-05	0.00112	CbGpPWpGaD
Mitotane—Asthenia—Oxcarbazepine—epilepsy syndrome	2.58e-05	0.000342	CcSEcCtD
Mitotane—Vomiting—Vigabatrin—epilepsy syndrome	2.58e-05	0.000341	CcSEcCtD
Mitotane—Skin disorder—Valproic Acid—epilepsy syndrome	2.58e-05	0.000341	CcSEcCtD
Mitotane—Urinary tract disorder—Topiramate—epilepsy syndrome	2.57e-05	0.00034	CcSEcCtD
Mitotane—CYP11B1—Metabolism—QDPR—epilepsy syndrome	2.57e-05	0.00112	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CA4—epilepsy syndrome	2.57e-05	0.00112	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—POMC—epilepsy syndrome	2.56e-05	0.00111	CbGpPWpGaD
Mitotane—Connective tissue disorder—Topiramate—epilepsy syndrome	2.56e-05	0.000339	CcSEcCtD
Mitotane—Nausea—Levetiracetam—epilepsy syndrome	2.56e-05	0.000339	CcSEcCtD
Mitotane—Rash—Vigabatrin—epilepsy syndrome	2.55e-05	0.000338	CcSEcCtD
Mitotane—Dizziness—Felbamate—epilepsy syndrome	2.55e-05	0.000338	CcSEcCtD
Mitotane—Dermatitis—Vigabatrin—epilepsy syndrome	2.55e-05	0.000338	CcSEcCtD
Mitotane—Urethral disorder—Topiramate—epilepsy syndrome	2.55e-05	0.000338	CcSEcCtD
Mitotane—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.54e-05	0.000337	CcSEcCtD
Mitotane—Vision blurred—Gabapentin—epilepsy syndrome	2.54e-05	0.000336	CcSEcCtD
Mitotane—Headache—Vigabatrin—epilepsy syndrome	2.54e-05	0.000336	CcSEcCtD
Mitotane—Hypertension—Pregabalin—epilepsy syndrome	2.54e-05	0.000336	CcSEcCtD
Mitotane—Vomiting—Diazepam—epilepsy syndrome	2.54e-05	0.000336	CcSEcCtD
Mitotane—Anorexia—Valproic Acid—epilepsy syndrome	2.53e-05	0.000335	CcSEcCtD
Mitotane—Tremor—Gabapentin—epilepsy syndrome	2.52e-05	0.000334	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.52e-05	0.00109	CbGpPWpGaD
Mitotane—Rash—Diazepam—epilepsy syndrome	2.52e-05	0.000333	CcSEcCtD
Mitotane—Dermatitis—Diazepam—epilepsy syndrome	2.51e-05	0.000333	CcSEcCtD
Mitotane—Visual impairment—Topiramate—epilepsy syndrome	2.51e-05	0.000332	CcSEcCtD
Mitotane—FDX1—Metabolism—CYP2D6—epilepsy syndrome	2.51e-05	0.00109	CbGpPWpGaD
Mitotane—Dizziness—Zonisamide—epilepsy syndrome	2.5e-05	0.000331	CcSEcCtD
Mitotane—Headache—Diazepam—epilepsy syndrome	2.5e-05	0.000331	CcSEcCtD
Mitotane—Diarrhoea—Clonazepam—epilepsy syndrome	2.49e-05	0.00033	CcSEcCtD
Mitotane—Anaemia—Gabapentin—epilepsy syndrome	2.49e-05	0.000329	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.48e-05	0.000329	CcSEcCtD
Mitotane—Hypotension—Valproic Acid—epilepsy syndrome	2.48e-05	0.000328	CcSEcCtD
Mitotane—Asthenia—Carbamazepine—epilepsy syndrome	2.48e-05	0.000328	CcSEcCtD
Mitotane—Diarrhoea—Phenytoin—epilepsy syndrome	2.48e-05	0.000328	CcSEcCtD
Mitotane—Nausea—Fosphenytoin—epilepsy syndrome	2.47e-05	0.000327	CcSEcCtD
Mitotane—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.46e-05	0.000326	CcSEcCtD
Mitotane—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.46e-05	0.000325	CcSEcCtD
Mitotane—Vomiting—Felbamate—epilepsy syndrome	2.45e-05	0.000325	CcSEcCtD
Mitotane—Rash—Felbamate—epilepsy syndrome	2.43e-05	0.000322	CcSEcCtD
Mitotane—Eye disorder—Topiramate—epilepsy syndrome	2.43e-05	0.000322	CcSEcCtD
Mitotane—Dermatitis—Felbamate—epilepsy syndrome	2.43e-05	0.000322	CcSEcCtD
Mitotane—Vertigo—Gabapentin—epilepsy syndrome	2.42e-05	0.00032	CcSEcCtD
Mitotane—Headache—Felbamate—epilepsy syndrome	2.42e-05	0.00032	CcSEcCtD
Mitotane—Confusional state—Pregabalin—epilepsy syndrome	2.42e-05	0.00032	CcSEcCtD
Mitotane—Flushing—Topiramate—epilepsy syndrome	2.42e-05	0.00032	CcSEcCtD
Mitotane—CYP11B1—Metabolism—COX3—epilepsy syndrome	2.41e-05	0.00105	CbGpPWpGaD
Mitotane—Dizziness—Clonazepam—epilepsy syndrome	2.41e-05	0.000319	CcSEcCtD
Mitotane—Nausea—Vigabatrin—epilepsy syndrome	2.41e-05	0.000318	CcSEcCtD
Mitotane—Vomiting—Zonisamide—epilepsy syndrome	2.4e-05	0.000318	CcSEcCtD
Mitotane—Asthenia—Lamotrigine—epilepsy syndrome	2.39e-05	0.000317	CcSEcCtD
Mitotane—Dizziness—Phenytoin—epilepsy syndrome	2.39e-05	0.000317	CcSEcCtD
Mitotane—FDX1—Metabolism—ADRA2A—epilepsy syndrome	2.39e-05	0.00104	CbGpPWpGaD
Mitotane—Rash—Zonisamide—epilepsy syndrome	2.38e-05	0.000315	CcSEcCtD
Mitotane—Infection—Pregabalin—epilepsy syndrome	2.38e-05	0.000315	CcSEcCtD
Mitotane—Paraesthesia—Valproic Acid—epilepsy syndrome	2.38e-05	0.000315	CcSEcCtD
Mitotane—Dermatitis—Zonisamide—epilepsy syndrome	2.38e-05	0.000315	CcSEcCtD
Mitotane—Dizziness—Oxcarbazepine—epilepsy syndrome	2.38e-05	0.000315	CcSEcCtD
Mitotane—FDX1—Metabolism—BCHE—epilepsy syndrome	2.38e-05	0.00103	CbGpPWpGaD
Mitotane—Nausea—Diazepam—epilepsy syndrome	2.37e-05	0.000314	CcSEcCtD
Mitotane—Headache—Zonisamide—epilepsy syndrome	2.37e-05	0.000313	CcSEcCtD
Mitotane—CYP11A1—Metabolism—PNPO—epilepsy syndrome	2.36e-05	0.00103	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NHLRC1—epilepsy syndrome	2.36e-05	0.00103	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GAMT—epilepsy syndrome	2.36e-05	0.00103	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—EPM2A—epilepsy syndrome	2.36e-05	0.00103	CbGpPWpGaD
Mitotane—Diarrhoea—Carbamazepine—epilepsy syndrome	2.36e-05	0.000313	CcSEcCtD
Mitotane—Angiopathy—Topiramate—epilepsy syndrome	2.36e-05	0.000313	CcSEcCtD
Mitotane—Shock—Pregabalin—epilepsy syndrome	2.36e-05	0.000312	CcSEcCtD
Mitotane—Somnolence—Valproic Acid—epilepsy syndrome	2.36e-05	0.000312	CcSEcCtD
Mitotane—Nervous system disorder—Pregabalin—epilepsy syndrome	2.35e-05	0.000311	CcSEcCtD
Mitotane—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.35e-05	0.000311	CcSEcCtD
Mitotane—Dyspepsia—Valproic Acid—epilepsy syndrome	2.33e-05	0.000309	CcSEcCtD
Mitotane—Skin disorder—Pregabalin—epilepsy syndrome	2.33e-05	0.000308	CcSEcCtD
Mitotane—Hypertension—Gabapentin—epilepsy syndrome	2.33e-05	0.000308	CcSEcCtD
Mitotane—Vomiting—Clonazepam—epilepsy syndrome	2.32e-05	0.000306	CcSEcCtD
Mitotane—Decreased appetite—Valproic Acid—epilepsy syndrome	2.31e-05	0.000305	CcSEcCtD
Mitotane—Vomiting—Phenytoin—epilepsy syndrome	2.3e-05	0.000304	CcSEcCtD
Mitotane—Rash—Clonazepam—epilepsy syndrome	2.3e-05	0.000304	CcSEcCtD
Mitotane—Dermatitis—Clonazepam—epilepsy syndrome	2.29e-05	0.000304	CcSEcCtD
Mitotane—Nausea—Felbamate—epilepsy syndrome	2.29e-05	0.000303	CcSEcCtD
Mitotane—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.29e-05	0.000303	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CACNA2D2—epilepsy syndrome	2.29e-05	0.000996	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—KCNB1—epilepsy syndrome	2.29e-05	0.000996	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PFKL—epilepsy syndrome	2.29e-05	0.000996	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLCO1A2—epilepsy syndrome	2.29e-05	0.000996	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC6A8—epilepsy syndrome	2.29e-05	0.000996	CbGpPWpGaD
Mitotane—Vomiting—Oxcarbazepine—epilepsy syndrome	2.29e-05	0.000303	CcSEcCtD
Mitotane—Anorexia—Pregabalin—epilepsy syndrome	2.29e-05	0.000302	CcSEcCtD
Mitotane—Dizziness—Carbamazepine—epilepsy syndrome	2.28e-05	0.000302	CcSEcCtD
Mitotane—Diarrhoea—Lamotrigine—epilepsy syndrome	2.28e-05	0.000302	CcSEcCtD
Mitotane—Headache—Clonazepam—epilepsy syndrome	2.28e-05	0.000302	CcSEcCtD
Mitotane—Rash—Phenytoin—epilepsy syndrome	2.28e-05	0.000302	CcSEcCtD
Mitotane—Mental disorder—Topiramate—epilepsy syndrome	2.28e-05	0.000302	CcSEcCtD
Mitotane—Dermatitis—Phenytoin—epilepsy syndrome	2.28e-05	0.000302	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.28e-05	0.000301	CcSEcCtD
Mitotane—Rash—Oxcarbazepine—epilepsy syndrome	2.27e-05	0.0003	CcSEcCtD
Mitotane—FDX1—Metabolism—SLC2A1—epilepsy syndrome	2.27e-05	0.000987	CbGpPWpGaD
Mitotane—Pain—Valproic Acid—epilepsy syndrome	2.27e-05	0.0003	CcSEcCtD
Mitotane—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.27e-05	0.0003	CcSEcCtD
Mitotane—Headache—Phenytoin—epilepsy syndrome	2.27e-05	0.0003	CcSEcCtD
Mitotane—Malnutrition—Topiramate—epilepsy syndrome	2.27e-05	0.0003	CcSEcCtD
Mitotane—Headache—Oxcarbazepine—epilepsy syndrome	2.25e-05	0.000298	CcSEcCtD
Mitotane—Nausea—Zonisamide—epilepsy syndrome	2.24e-05	0.000297	CcSEcCtD
Mitotane—FDX1—Metabolism—PLCB1—epilepsy syndrome	2.24e-05	0.000976	CbGpPWpGaD
Mitotane—Hypotension—Pregabalin—epilepsy syndrome	2.24e-05	0.000296	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.24e-05	0.000973	CbGpPWpGaD
Mitotane—FDX1—Metabolism—TH—epilepsy syndrome	2.24e-05	0.000973	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.22e-05	0.000967	CbGpPWpGaD
Mitotane—Dysgeusia—Topiramate—epilepsy syndrome	2.22e-05	0.000294	CcSEcCtD
Mitotane—Confusional state—Gabapentin—epilepsy syndrome	2.22e-05	0.000293	CcSEcCtD
Mitotane—Dizziness—Lamotrigine—epilepsy syndrome	2.21e-05	0.000292	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.2e-05	0.000958	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—QDPR—epilepsy syndrome	2.2e-05	0.000956	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CA4—epilepsy syndrome	2.2e-05	0.000956	CbGpPWpGaD
Mitotane—Vomiting—Carbamazepine—epilepsy syndrome	2.2e-05	0.000291	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—POMC—epilepsy syndrome	2.19e-05	0.000953	CbGpPWpGaD
Mitotane—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.19e-05	0.000289	CcSEcCtD
Mitotane—Infection—Gabapentin—epilepsy syndrome	2.18e-05	0.000289	CcSEcCtD
Mitotane—Rash—Carbamazepine—epilepsy syndrome	2.18e-05	0.000288	CcSEcCtD
Mitotane—Dermatitis—Carbamazepine—epilepsy syndrome	2.18e-05	0.000288	CcSEcCtD
Mitotane—Nausea—Clonazepam—epilepsy syndrome	2.16e-05	0.000286	CcSEcCtD
Mitotane—Headache—Carbamazepine—epilepsy syndrome	2.16e-05	0.000286	CcSEcCtD
Mitotane—Shock—Gabapentin—epilepsy syndrome	2.16e-05	0.000286	CcSEcCtD
Mitotane—Nervous system disorder—Gabapentin—epilepsy syndrome	2.16e-05	0.000285	CcSEcCtD
Mitotane—Paraesthesia—Pregabalin—epilepsy syndrome	2.15e-05	0.000285	CcSEcCtD
Mitotane—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.15e-05	0.000285	CcSEcCtD
Mitotane—Nausea—Phenytoin—epilepsy syndrome	2.15e-05	0.000284	CcSEcCtD
Mitotane—Nausea—Oxcarbazepine—epilepsy syndrome	2.14e-05	0.000283	CcSEcCtD
Mitotane—Vision blurred—Topiramate—epilepsy syndrome	2.14e-05	0.000283	CcSEcCtD
Mitotane—Skin disorder—Gabapentin—epilepsy syndrome	2.14e-05	0.000283	CcSEcCtD
Mitotane—Somnolence—Pregabalin—epilepsy syndrome	2.13e-05	0.000282	CcSEcCtD
Mitotane—Tremor—Topiramate—epilepsy syndrome	2.12e-05	0.000281	CcSEcCtD
Mitotane—Vomiting—Lamotrigine—epilepsy syndrome	2.12e-05	0.000281	CcSEcCtD
Mitotane—Rash—Lamotrigine—epilepsy syndrome	2.1e-05	0.000278	CcSEcCtD
Mitotane—Dermatitis—Lamotrigine—epilepsy syndrome	2.1e-05	0.000278	CcSEcCtD
Mitotane—Body temperature increased—Valproic Acid—epilepsy syndrome	2.1e-05	0.000277	CcSEcCtD
Mitotane—Anorexia—Gabapentin—epilepsy syndrome	2.1e-05	0.000277	CcSEcCtD
Mitotane—Anaemia—Topiramate—epilepsy syndrome	2.09e-05	0.000277	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ATIC—epilepsy syndrome	2.09e-05	0.000911	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—UPB1—epilepsy syndrome	2.09e-05	0.000911	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NEU1—epilepsy syndrome	2.09e-05	0.000911	CbGpPWpGaD
Mitotane—Headache—Lamotrigine—epilepsy syndrome	2.09e-05	0.000277	CcSEcCtD
Mitotane—Decreased appetite—Pregabalin—epilepsy syndrome	2.08e-05	0.000276	CcSEcCtD
Mitotane—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.07e-05	0.000274	CcSEcCtD
Mitotane—CYP11A1—Metabolism—COX3—epilepsy syndrome	2.07e-05	0.000899	CbGpPWpGaD
Mitotane—Hypotension—Gabapentin—epilepsy syndrome	2.05e-05	0.000272	CcSEcCtD
Mitotane—Nausea—Carbamazepine—epilepsy syndrome	2.05e-05	0.000271	CcSEcCtD
Mitotane—Pain—Pregabalin—epilepsy syndrome	2.05e-05	0.000271	CcSEcCtD
Mitotane—Vertigo—Topiramate—epilepsy syndrome	2.04e-05	0.000269	CcSEcCtD
Mitotane—CYP11B1—Metabolism—HSD17B4—epilepsy syndrome	2.02e-05	0.000877	CbGpPWpGaD
Mitotane—Nausea—Lamotrigine—epilepsy syndrome	1.98e-05	0.000262	CcSEcCtD
Mitotane—Feeling abnormal—Pregabalin—epilepsy syndrome	1.98e-05	0.000261	CcSEcCtD
Mitotane—Paraesthesia—Gabapentin—epilepsy syndrome	1.97e-05	0.000261	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CACNA2D2—epilepsy syndrome	1.96e-05	0.000852	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLCO1A2—epilepsy syndrome	1.96e-05	0.000852	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—KCNB1—epilepsy syndrome	1.96e-05	0.000852	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PFKL—epilepsy syndrome	1.96e-05	0.000852	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC6A8—epilepsy syndrome	1.96e-05	0.000852	CbGpPWpGaD
Mitotane—Hypertension—Topiramate—epilepsy syndrome	1.96e-05	0.000259	CcSEcCtD
Mitotane—Somnolence—Gabapentin—epilepsy syndrome	1.95e-05	0.000259	CcSEcCtD
Mitotane—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.95e-05	0.000259	CcSEcCtD
Mitotane—CYP11B1—Metabolism—GBE1—epilepsy syndrome	1.95e-05	0.000847	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PPP1R3C—epilepsy syndrome	1.95e-05	0.000847	CbGpPWpGaD
Mitotane—Dyspepsia—Gabapentin—epilepsy syndrome	1.94e-05	0.000256	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.92e-05	0.000254	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.91e-05	0.000833	CbGpPWpGaD
Mitotane—Decreased appetite—Gabapentin—epilepsy syndrome	1.91e-05	0.000253	CcSEcCtD
Mitotane—Asthenia—Valproic Acid—epilepsy syndrome	1.9e-05	0.000252	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.9e-05	0.000828	CbGpPWpGaD
Mitotane—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.9e-05	0.000251	CcSEcCtD
Mitotane—Body temperature increased—Pregabalin—epilepsy syndrome	1.9e-05	0.000251	CcSEcCtD
Mitotane—Pain—Gabapentin—epilepsy syndrome	1.88e-05	0.000249	CcSEcCtD
Mitotane—FDX1—Metabolism—HMOX1—epilepsy syndrome	1.87e-05	0.000812	CbGpPWpGaD
Mitotane—Confusional state—Topiramate—epilepsy syndrome	1.87e-05	0.000247	CcSEcCtD
Mitotane—FDX1—Metabolism—CAT—epilepsy syndrome	1.84e-05	0.000801	CbGpPWpGaD
Mitotane—Infection—Topiramate—epilepsy syndrome	1.84e-05	0.000243	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ASAH1—epilepsy syndrome	1.83e-05	0.000796	CbGpPWpGaD
Mitotane—Shock—Topiramate—epilepsy syndrome	1.82e-05	0.000241	CcSEcCtD
Mitotane—Diarrhoea—Valproic Acid—epilepsy syndrome	1.81e-05	0.00024	CcSEcCtD
Mitotane—Nervous system disorder—Topiramate—epilepsy syndrome	1.81e-05	0.00024	CcSEcCtD
Mitotane—Feeling abnormal—Gabapentin—epilepsy syndrome	1.81e-05	0.00024	CcSEcCtD
Mitotane—Thrombocytopenia—Topiramate—epilepsy syndrome	1.81e-05	0.00024	CcSEcCtD
Mitotane—Skin disorder—Topiramate—epilepsy syndrome	1.8e-05	0.000238	CcSEcCtD
Mitotane—FDX1—Metabolism—ABCB1—epilepsy syndrome	1.79e-05	0.000779	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—UPB1—epilepsy syndrome	1.79e-05	0.000779	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ATIC—epilepsy syndrome	1.79e-05	0.000779	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NEU1—epilepsy syndrome	1.79e-05	0.000779	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—STXBP1—epilepsy syndrome	1.78e-05	0.000775	CbGpPWpGaD
Mitotane—Hypersensitivity—Pregabalin—epilepsy syndrome	1.77e-05	0.000234	CcSEcCtD
Mitotane—Anorexia—Topiramate—epilepsy syndrome	1.76e-05	0.000233	CcSEcCtD
Mitotane—Dizziness—Valproic Acid—epilepsy syndrome	1.75e-05	0.000232	CcSEcCtD
Mitotane—Body temperature increased—Gabapentin—epilepsy syndrome	1.74e-05	0.00023	CcSEcCtD
Mitotane—CYP11B1—Metabolism—NT5E—epilepsy syndrome	1.73e-05	0.000755	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALAD—epilepsy syndrome	1.73e-05	0.000755	CbGpPWpGaD
Mitotane—Hypotension—Topiramate—epilepsy syndrome	1.73e-05	0.000229	CcSEcCtD
Mitotane—CYP11A1—Metabolism—HSD17B4—epilepsy syndrome	1.72e-05	0.00075	CbGpPWpGaD
Mitotane—Asthenia—Pregabalin—epilepsy syndrome	1.72e-05	0.000228	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—AKT1—epilepsy syndrome	1.69e-05	0.000737	CbGpPWpGaD
Mitotane—Vomiting—Valproic Acid—epilepsy syndrome	1.69e-05	0.000223	CcSEcCtD
Mitotane—Rash—Valproic Acid—epilepsy syndrome	1.67e-05	0.000221	CcSEcCtD
Mitotane—Dermatitis—Valproic Acid—epilepsy syndrome	1.67e-05	0.000221	CcSEcCtD
Mitotane—CYP11A1—Metabolism—PPP1R3C—epilepsy syndrome	1.67e-05	0.000724	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GBE1—epilepsy syndrome	1.67e-05	0.000724	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GPX1—epilepsy syndrome	1.67e-05	0.000724	CbGpPWpGaD
Mitotane—Headache—Valproic Acid—epilepsy syndrome	1.66e-05	0.00022	CcSEcCtD
Mitotane—Paraesthesia—Topiramate—epilepsy syndrome	1.66e-05	0.00022	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ALDH7A1—epilepsy syndrome	1.66e-05	0.00072	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CACNA1A—epilepsy syndrome	1.66e-05	0.00072	CbGpPWpGaD
Mitotane—Somnolence—Topiramate—epilepsy syndrome	1.64e-05	0.000218	CcSEcCtD
Mitotane—Diarrhoea—Pregabalin—epilepsy syndrome	1.64e-05	0.000217	CcSEcCtD
Mitotane—Dyspepsia—Topiramate—epilepsy syndrome	1.63e-05	0.000215	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.63e-05	0.000708	CbGpPWpGaD
Mitotane—Hypersensitivity—Gabapentin—epilepsy syndrome	1.62e-05	0.000214	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ST3GAL3—epilepsy syndrome	1.62e-05	0.000705	CbGpPWpGaD
Mitotane—Decreased appetite—Topiramate—epilepsy syndrome	1.61e-05	0.000213	CcSEcCtD
Mitotane—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.6e-05	0.000211	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ADSL—epilepsy syndrome	1.59e-05	0.00069	CbGpPWpGaD
Mitotane—Dizziness—Pregabalin—epilepsy syndrome	1.59e-05	0.00021	CcSEcCtD
Mitotane—Pain—Topiramate—epilepsy syndrome	1.58e-05	0.000209	CcSEcCtD
Mitotane—Asthenia—Gabapentin—epilepsy syndrome	1.58e-05	0.000209	CcSEcCtD
Mitotane—Nausea—Valproic Acid—epilepsy syndrome	1.58e-05	0.000208	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ASAH1—epilepsy syndrome	1.57e-05	0.000681	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GLUL—epilepsy syndrome	1.56e-05	0.000677	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CACNA1D—epilepsy syndrome	1.53e-05	0.000665	CbGpPWpGaD
Mitotane—Vomiting—Pregabalin—epilepsy syndrome	1.52e-05	0.000202	CcSEcCtD
Mitotane—Feeling abnormal—Topiramate—epilepsy syndrome	1.52e-05	0.000202	CcSEcCtD
Mitotane—CYP11A1—Metabolism—STXBP1—epilepsy syndrome	1.52e-05	0.000663	CbGpPWpGaD
Mitotane—Rash—Pregabalin—epilepsy syndrome	1.51e-05	0.0002	CcSEcCtD
Mitotane—Dermatitis—Pregabalin—epilepsy syndrome	1.51e-05	0.0002	CcSEcCtD
Mitotane—Diarrhoea—Gabapentin—epilepsy syndrome	1.5e-05	0.000199	CcSEcCtD
Mitotane—Headache—Pregabalin—epilepsy syndrome	1.5e-05	0.000199	CcSEcCtD
Mitotane—CYP11A1—Metabolism—NT5E—epilepsy syndrome	1.48e-05	0.000646	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALAD—epilepsy syndrome	1.48e-05	0.000646	CbGpPWpGaD
Mitotane—Body temperature increased—Topiramate—epilepsy syndrome	1.46e-05	0.000193	CcSEcCtD
Mitotane—FDX1—Metabolism—AGT—epilepsy syndrome	1.46e-05	0.000635	CbGpPWpGaD
Mitotane—Dizziness—Gabapentin—epilepsy syndrome	1.45e-05	0.000192	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—AKT1—epilepsy syndrome	1.45e-05	0.00063	CbGpPWpGaD
Mitotane—FDX1—Metabolism—APOE—epilepsy syndrome	1.43e-05	0.000622	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TXNRD1—epilepsy syndrome	1.43e-05	0.000622	CbGpPWpGaD
Mitotane—Nausea—Pregabalin—epilepsy syndrome	1.42e-05	0.000188	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CACNA1A—epilepsy syndrome	1.42e-05	0.000616	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALDH7A1—epilepsy syndrome	1.42e-05	0.000616	CbGpPWpGaD
Mitotane—Vomiting—Gabapentin—epilepsy syndrome	1.4e-05	0.000185	CcSEcCtD
Mitotane—CYP11B1—Metabolism—AQP1—epilepsy syndrome	1.39e-05	0.000603	CbGpPWpGaD
Mitotane—Rash—Gabapentin—epilepsy syndrome	1.39e-05	0.000183	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ST3GAL3—epilepsy syndrome	1.39e-05	0.000603	CbGpPWpGaD
Mitotane—Dermatitis—Gabapentin—epilepsy syndrome	1.38e-05	0.000183	CcSEcCtD
Mitotane—Headache—Gabapentin—epilepsy syndrome	1.38e-05	0.000182	CcSEcCtD
Mitotane—Hypersensitivity—Topiramate—epilepsy syndrome	1.36e-05	0.00018	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ADSL—epilepsy syndrome	1.36e-05	0.000591	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.33e-05	0.00058	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GLUL—epilepsy syndrome	1.33e-05	0.000579	CbGpPWpGaD
Mitotane—Asthenia—Topiramate—epilepsy syndrome	1.33e-05	0.000176	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CACNA1D—epilepsy syndrome	1.31e-05	0.000568	CbGpPWpGaD
Mitotane—Nausea—Gabapentin—epilepsy syndrome	1.31e-05	0.000173	CcSEcCtD
Mitotane—Diarrhoea—Topiramate—epilepsy syndrome	1.27e-05	0.000167	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CHRM3—epilepsy syndrome	1.25e-05	0.000546	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—KCNJ11—epilepsy syndrome	1.25e-05	0.000546	CbGpPWpGaD
Mitotane—FDX1—Metabolism—POMC—epilepsy syndrome	1.23e-05	0.000535	CbGpPWpGaD
Mitotane—Dizziness—Topiramate—epilepsy syndrome	1.22e-05	0.000162	CcSEcCtD
Mitotane—CYP11A1—Metabolism—TXNRD1—epilepsy syndrome	1.22e-05	0.000532	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AQP1—epilepsy syndrome	1.19e-05	0.000516	CbGpPWpGaD
Mitotane—Vomiting—Topiramate—epilepsy syndrome	1.18e-05	0.000156	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.17e-05	0.000508	CbGpPWpGaD
Mitotane—Rash—Topiramate—epilepsy syndrome	1.17e-05	0.000154	CcSEcCtD
Mitotane—Dermatitis—Topiramate—epilepsy syndrome	1.17e-05	0.000154	CcSEcCtD
Mitotane—Headache—Topiramate—epilepsy syndrome	1.16e-05	0.000153	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.14e-05	0.000498	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.14e-05	0.000496	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ALB—epilepsy syndrome	1.12e-05	0.000487	CbGpPWpGaD
Mitotane—Nausea—Topiramate—epilepsy syndrome	1.1e-05	0.000145	CcSEcCtD
Mitotane—CYP11A1—Metabolism—KCNJ11—epilepsy syndrome	1.07e-05	0.000467	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CHRM3—epilepsy syndrome	1.07e-05	0.000467	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ABCG2—epilepsy syndrome	1.02e-05	0.000445	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.99e-06	0.000435	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP2C19—epilepsy syndrome	9.96e-06	0.000434	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP11A1—epilepsy syndrome	9.9e-06	0.000431	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.83e-06	0.000428	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTGS2—epilepsy syndrome	9.8e-06	0.000426	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.79e-06	0.000426	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.96e-06	0.00039	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP2D6—epilepsy syndrome	8.94e-06	0.000389	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ABCG2—epilepsy syndrome	8.75e-06	0.000381	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP2C19—epilepsy syndrome	8.52e-06	0.000371	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ADRA2A—epilepsy syndrome	8.51e-06	0.00037	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—BCHE—epilepsy syndrome	8.47e-06	0.000369	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.41e-06	0.000366	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC2A1—epilepsy syndrome	8.08e-06	0.000352	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PLCB1—epilepsy syndrome	7.99e-06	0.000348	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TH—epilepsy syndrome	7.97e-06	0.000347	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.84e-06	0.000341	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.67e-06	0.000334	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP2D6—epilepsy syndrome	7.65e-06	0.000333	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ADRA2A—epilepsy syndrome	7.28e-06	0.000317	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—BCHE—epilepsy syndrome	7.25e-06	0.000315	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC2A1—epilepsy syndrome	6.92e-06	0.000301	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PLCB1—epilepsy syndrome	6.84e-06	0.000298	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TH—epilepsy syndrome	6.82e-06	0.000296	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.71e-06	0.000292	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—HMOX1—epilepsy syndrome	6.65e-06	0.000289	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CAT—epilepsy syndrome	6.56e-06	0.000285	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ABCB1—epilepsy syndrome	6.38e-06	0.000278	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GPX1—epilepsy syndrome	5.93e-06	0.000258	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—HMOX1—epilepsy syndrome	5.69e-06	0.000247	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CAT—epilepsy syndrome	5.61e-06	0.000244	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ABCB1—epilepsy syndrome	5.46e-06	0.000238	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AGT—epilepsy syndrome	5.2e-06	0.000226	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—APOE—epilepsy syndrome	5.1e-06	0.000222	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GPX1—epilepsy syndrome	5.08e-06	0.000221	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AKT1—epilepsy syndrome	4.93e-06	0.000214	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AGT—epilepsy syndrome	4.45e-06	0.000194	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—POMC—epilepsy syndrome	4.38e-06	0.00019	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—APOE—epilepsy syndrome	4.36e-06	0.00019	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALB—epilepsy syndrome	3.99e-06	0.000174	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—POMC—epilepsy syndrome	3.75e-06	0.000163	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTGS2—epilepsy syndrome	3.49e-06	0.000152	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ALB—epilepsy syndrome	3.42e-06	0.000149	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTGS2—epilepsy syndrome	2.99e-06	0.00013	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKT1—epilepsy syndrome	1.76e-06	7.64e-05	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKT1—epilepsy syndrome	1.5e-06	6.53e-05	CbGpPWpGaD
